Health advisories: when good intentions go bad
- 8 April 2008
- journal article
- editorial
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 178 (8) , 1025-1026
- https://doi.org/10.1503/cmaj.080391
Abstract
Health advisories for drug therapies are issued by regulatory bodies such as Health Canada with the best of intentions: to protect the public. Such advisories are backed by teams of internationally renowned experts convened by these regulatory bodies to review and interpret the available scientificKeywords
This publication has 12 references indexed in Scilit:
- Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adultsCMAJ : Canadian Medical Association Journal, 2008
- The Treatment for Adolescents With Depression Study (TADS)Archives of General Psychiatry, 2007
- Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and AdolescentsAmerican Journal of Psychiatry, 2007
- A Developmental Perspective on the Controversy Surrounding the Use of SSRIs to Treat Pediatric DepressionAmerican Journal of Psychiatry, 2007
- Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant TreatmentJAMA, 2007
- The Effect of Antidepressant Warnings on Prescribing Trends in Ontario, CanadaAmerican Journal of Public Health, 2007
- Antidepressant Drug Therapy and Suicide in Severely Depressed Children and AdultsArchives of General Psychiatry, 2006
- Suicidality in Pediatric Patients Treated With Antidepressant DrugsArchives of General Psychiatry, 2006
- UK bans, Health Canada warns about antidepressantsCMAJ : Canadian Medical Association Journal, 2004
- How Much Information About Adverse Effects of Medication Do Patients Want From Physicians?Archives of internal medicine (1960), 2001